Starch Capsules Market Size & Share, by Source Material-Blended (Pectin, Carrageenan, Gelatin); Form (Liquid, Powder); Size (0,00 & 000, 0 to 2, 3 to 5, Above 5); Application (Health Supplements, Antibiotics & Anti-Inflammatory, Cardiovascular); Product (Hard, Soft Capsules), End-user (Pharmaceutical, Nutraceutical Companies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

Market Drivers and Challenges

Growth Indicators

• Growing Incidences of Cardiovascular Diseases to Drive Market Growth
  According to the statistics by the World Health Organization, in the year 2016, around 17.9 million died from cardiovascular diseases.
  
  In the recent era, numerous people are suffering from cardiovascular diseases, and the numbers are increasing at an alarming rate. The high risks of cardiovascular diseases can be attributed to the poor behavioral factors, that include consumption of tobacco, alcohol and other unhealthy diets. The consumption of such products raises the blood pressure in the human body and also imbalances the body functions. The healthcare practitioners are increasingly prescribing medicines that are made up of starch capsules as these capsules are known to possess several benefits. In the healthcare industry, the starch capsules are considered as a very efficient alternative delivery system for orally administered compound. On the other hand, the starch-based capsules are known for their cost-effectiveness, which has further created a shift in the preference of the customers towards the consumption of these capsules.
• Increasing Healthcare Expenditure to Drive Market Growth
  According to the statistics by the Peterson-KFF Health System Tracker, the total national health expenditure in the U.S. increased from USD 2593.16 billion in the year 2010 to USD 3649.386 billion in the year 2018.
  
  The increasing investment in various international healthcare programs funded by the government of nations worldwide and other organizations, such as the World Health Organization (WHO), is one of the major factors anticipated to drive the market growth. The healthcare spending around the globe is increasing on account of factors, such as the presence of an ageing population, increase in cost of medical services, and others. Moreover, a significant amount of investments is also being made by various public and private companies globally towards the rising research and developments in the healthcare industry. Such factors have led to the development of the healthcare infrastructure as a whole and also has provided greater accessibility to high-end treatment solutions to the patients, raising the need for advanced pharmaceutical products, such as starch capsules. Such a factor is therefore anticipated to drive the starch capsules market growth.

Challenges

• Stringent Entry Barriers to Limit Market Growth
  The global starch capsules market retains a limited number of players with a confined amount of price options available to the customers. This is due to the stringent regulatory norms of the government and severe cost constraints. Moreover, the production of the starch capsules requires huge investments, therefore prohibiting new entrants to enter the existing market. Also, the fluctuating prices of raw materials, such as carrageenan and pectin is also expected to hamper the starch capsules market growth.